Nanjing Junzhuo Biotechnology Co., Ltd. has officially launched its new website. The upgraded site gives customers and partners a clearer way to review product information, technical content, bilingual pages, and contact options.
The site is organized around products, applications, news, services, and contact, making it easier for R&D teams, manufacturers, and project partners to find relevant biomaterials information.
A Clearer Product Portfolio
Nanjing Junzhuo focuses on the research, production, and custom development of high-end biomaterials. The new site presents the company's work across hydroxyapatite, beta-tricalcium phosphate, bioceramics, and related new materials in a more structured way.
Hydroxyapatite (CaHA) remains one of the main product areas featured on the site. Depending on project needs, Junzhuo can support powders, microspheres, and related material forms for bone repair, coatings, research, and aesthetic-material development.
Broader Material Coverage
In addition to CaHA-related materials, the website also introduces beta-tricalcium phosphate (β-TCP), biphasic calcium phosphate (BCP), calcium silicate (CS), calcium sulfate hemihydrate (CSH), and other material categories. Each material can be reviewed in terms of support requirements, degradation behavior, bioactivity, processing method, and intended application.
Hydroxyapatite microspheres are also highlighted as an important product line. Particle-size distribution, morphology, pore structure, and solid or porous formats can all be discussed based on end-use requirements.
Products, Services, and Ongoing Updates
Beyond standard products, Junzhuo also supports custom development around particle size, morphology, crystal phase, purity, packaging, technical files, and intended applications. That helps align sample evaluation, technical review, and later project follow-up more efficiently.
With the launch of the new website, Junzhuo will continue to publish product information, technical articles, company news, and bilingual updates for domestic and international partners.